Quick Answer
Cocrystal Pharma, Inc. reported Net Income of -$8.83 million for fiscal year 2025.
Cocrystal Pharma, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.83M | +49.5% |
| 2024 | -$17.50M | +2.7% |
| 2023 | -$17.98M | +53.7% |
| 2022 | -$38.84M | -173.8% |
| 2021 | -$14.19M | -47.0% |
| 2020 | -$9.65M | +80.0% |
| 2019 | -$48.17M | +1.8% |
| 2018 | -$49.05M | -7901.3% |
| 2017 | -$613.0K | +99.2% |
| 2016 | -$74.87M | -49.4% |
| 2015 | -$50.12M | -50528.3% |
| 2014 | -$99.0K | +97.5% |
| 2013 | -$3.89M | +51.2% |
| 2012 | -$7.96M | -45.9% |
| 2011 | -$5.46M | -1606.4% |
| 2010 | -$319.8K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.05M | +58.5% | +0.3% |
| June 30, 2025 | -$2.06M | +61.5% | +10.7% |
| March 31, 2025 | -$2.30M | +41.8% | +53.4% |
| September 30, 2024 | -$4.94M | -18.6% | +7.6% |
| June 30, 2024 | -$5.34M | -28.3% | -35.1% |
| March 31, 2024 | -$3.96M | +23.8% | +5.0% |
| September 30, 2023 | -$4.17M | +26.9% | +0.0% |
| June 30, 2023 | -$4.17M | +82.9% | +19.7% |
- Cocrystal Pharma, Inc. showed an increase of +49.5% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Cocrystal Pharma, Inc.’s net income has declined by 2661.3% (from -$319.8 thousand to -$8.83 million).
- The most recent figure is from Cocrystal Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: